Impaired Heat Shock Protein Expression in Activated T Cells in B-Cell Lymphoma

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Heat shock proteins (HSPs) are vital molecular chaperones involved in protein homeostasis and immune cell modulation.
• The specific role of HSPs in T cell activation remains largely unexplored.
• Immune checkpoints like PD-1 and CTLA-4 are critical in regulating T cell responses.

Purpose of the Study:

• To investigate the role of HSPs in T cell activation, particularly in the context of B-cell lymphoma (BCL).
• To examine the expression of HSPs, immune checkpoints, and STAT3 in activated T cells from BCL patients.
• To evaluate the effects of HSP90 inhibition on T cell markers and function in BCL patients.

Main Methods:

• Analyzing HSP expression in CD3/CD28-stimulated T cells.
• Assessing intracellular and extracellular HSPs, PD-1, CTLA-4, and STAT3 in T cells from BCL patients.
• Investigating the impact of HSP90 inhibition, alone or combined with immune checkpoint inhibitors, on T cell surface markers and degranulation.

Main Results:

• HSPs are upregulated upon CD3/CD28 stimulation, indicating TCR-mediated regulation.
• BCL patients exhibit dysregulated expression of HSPs and immune checkpoints in activated T cells.
• HSP90 inhibition reduced CD4 and CD8 markers and differentially affected T cell degranulation in BCL patients.

Conclusions:

• HSP90 inhibition influences T cell function in BCL patients, suggesting a role for HSPs in T cell-mediated immunity.
• These findings highlight potential novel immunological targets for cancer therapy.
• Further research into HSP functions in immune cells could improve cancer treatment strategies.